Results of late-breaking developments from the POSEIDON Phase III trial revealed improved overall survival with a limited course of five cycles of tremelimumab added to durvalumab plus platinum chemotherapy.
Click video to watch this presentation by Dr Yuan Yuan, MD, PhD, a breast medical oncologist and physician-scientist who specializes in triple-negative breast cancer and breast cancer immunotherapy. Dr Yuan completed her medical degree in China and a fellowship in hematology and oncology at NYU. Additionally, she holds a PhD in biochemistry and molecular biology from the University of California, Riverside.
Watch Dr Yuan Yuan, MD, PhD, walk through a hypothetical patient case centered on potential management strategies for grade 2 diarrhea and grade 4 neutropenia that may be experienced with a treatment option for patients with certain types of metastatic breast cancer. Follow along with the case-based questions in the video by answering the questions below to assess what you learned!
<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->